Catalyst Pharmaceuticals (CPRX) Competitors $21.12 -0.21 (-0.98%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$21.06 -0.05 (-0.26%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CPRX vs. VRNA, BBIO, BPMC, ROIV, LEGN, ELAN, RGC, RVMD, GRFS, and TGTXShould you be buying Catalyst Pharmaceuticals stock or one of its competitors? The main competitors of Catalyst Pharmaceuticals include Verona Pharma PLC American Depositary Share (VRNA), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Roivant Sciences (ROIV), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Regencell Bioscience (RGC), Revolution Medicines (RVMD), Grifols (GRFS), and TG Therapeutics (TGTX). These companies are all part of the "pharmaceutical products" industry. Catalyst Pharmaceuticals vs. Its Competitors Verona Pharma PLC American Depositary Share BridgeBio Pharma Blueprint Medicines Roivant Sciences Legend Biotech Elanco Animal Health Regencell Bioscience Revolution Medicines Grifols TG Therapeutics Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) and Catalyst Pharmaceuticals (NASDAQ:CPRX) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends. Do insiders & institutionals have more ownership in VRNA or CPRX? 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. Comparatively, 79.2% of Catalyst Pharmaceuticals shares are owned by institutional investors. 4.8% of Verona Pharma PLC American Depositary Share shares are owned by insiders. Comparatively, 10.4% of Catalyst Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend VRNA or CPRX? Verona Pharma PLC American Depositary Share presently has a consensus target price of $109.00, indicating a potential upside of 3.63%. Catalyst Pharmaceuticals has a consensus target price of $32.83, indicating a potential upside of 55.46%. Given Catalyst Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Catalyst Pharmaceuticals is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verona Pharma PLC American Depositary Share 0 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.15Catalyst Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Which has higher earnings and valuation, VRNA or CPRX? Catalyst Pharmaceuticals has higher revenue and earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than Catalyst Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerona Pharma PLC American Depositary Share$42.28M211.78-$173.42M-$2.00-52.59Catalyst Pharmaceuticals$491.73M5.24$163.89M$1.5713.45 Which has more volatility and risk, VRNA or CPRX? Verona Pharma PLC American Depositary Share has a beta of 0.12, indicating that its stock price is 88% less volatile than the S&P 500. Comparatively, Catalyst Pharmaceuticals has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Is VRNA or CPRX more profitable? Catalyst Pharmaceuticals has a net margin of 36.91% compared to Verona Pharma PLC American Depositary Share's net margin of 0.00%. Catalyst Pharmaceuticals' return on equity of 42.45% beat Verona Pharma PLC American Depositary Share's return on equity.Company Net Margins Return on Equity Return on Assets Verona Pharma PLC American Depositary ShareN/A -69.65% -28.00% Catalyst Pharmaceuticals 36.91%42.45%36.59% Does the media refer more to VRNA or CPRX? In the previous week, Verona Pharma PLC American Depositary Share and Verona Pharma PLC American Depositary Share both had 11 articles in the media. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.45 beat Catalyst Pharmaceuticals' score of 1.18 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Verona Pharma PLC American Depositary Share 8 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Catalyst Pharmaceuticals 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCatalyst Pharmaceuticals beats Verona Pharma PLC American Depositary Share on 13 of the 16 factors compared between the two stocks. Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CPRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPRX vs. The Competition Export to ExcelMetricCatalyst PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.60B$2.46B$5.48B$9.52BDividend YieldN/A1.81%4.73%4.08%P/E Ratio13.458.9728.6723.80Price / Sales5.24437.63373.5466.64Price / Cash8.72157.7635.4557.96Price / Book3.464.838.275.55Net Income$163.89M$31.62M$3.24B$259.03M7 Day Performance0.72%-5.28%-3.69%-4.59%1 Month Performance-1.54%4.38%4.33%4.46%1 Year Performance28.23%-2.49%25.95%18.03% Catalyst Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPRXCatalyst Pharmaceuticals4.8982 of 5 stars$21.12-1.0%$32.83+55.5%+24.7%$2.60B$491.73M13.4580Positive NewsUpcoming EarningsVRNAVerona Pharma PLC American Depositary Share2.1954 of 5 stars$104.90flat$109.00+3.9%+365.2%$8.93B$42.28M-52.4530Positive NewsUpcoming EarningsShort Interest ↑BBIOBridgeBio Pharma4.7123 of 5 stars$45.90-1.3%$61.50+34.0%+80.9%$8.72B$221.90M-13.00400Upcoming EarningsAnalyst ForecastBPMCBlueprint Medicines1.0661 of 5 stars$129.46flat$128.25-0.9%N/A$8.36B$562.12M-52.41640Upcoming EarningsROIVRoivant Sciences1.8472 of 5 stars$11.48+0.3%$16.50+43.7%+6.5%$7.80B$29.05M-45.92860Upcoming EarningsLEGNLegend Biotech3.5917 of 5 stars$42.23+1.5%$73.33+73.7%-29.5%$7.76B$627.24M-71.582,609Positive NewsELANElanco Animal Health3.8056 of 5 stars$14.67-0.8%$16.00+9.1%+5.9%$7.28B$4.44B19.829,000Positive NewsUpcoming EarningsRGCRegencell Bioscience0.0502 of 5 stars$14.40-0.7%N/AN/A$7.17BN/A0.0010Positive NewsRVMDRevolution Medicines4.467 of 5 stars$38.42+0.3%$68.91+79.4%-19.1%$7.16B$11.58M-9.61250News CoveragePositive NewsUpcoming EarningsGRFSGrifols3.1017 of 5 stars$10.00+0.6%$10.30+3.0%+41.1%$6.88B$7.81B8.5523,822Dividend AnnouncementTGTXTG Therapeutics4.0843 of 5 stars$37.42-1.3%$43.80+17.0%+85.0%$5.94B$329M155.92290Positive NewsUpcoming Earnings Related Companies and Tools Related Companies VRNA Alternatives BBIO Alternatives BPMC Alternatives ROIV Alternatives LEGN Alternatives ELAN Alternatives RGC Alternatives RVMD Alternatives GRFS Alternatives TGTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CPRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPRX Stock Alerts